Search
Displaying 131 - 140 of 275
Omeros Corporation is sponsoring the ARTEMIS-IGAN clinical trial, a randomized, double-blind, placebo-controlled, Phase 3 study of the safety and efficacy of narsoplimab in patients with immunoglobulin A (IgA) nephropathy.
The chances of losing one's mental faculties with age are increased in older adults with chronic kidney disease, according to two research reports in the August issue of American Journal of Kidney Diseases, the official journal of the National Kidney Foundation.
The good news is that there are medications that decrease albuminuria or protein in the urine, one of the earliest signs of kidney disease, and therefore may prevent or delay...